The TP53 gene network in a postgenomic era

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• TP53 pathway inactivation is a hallmark of human cancers.
• While TP53 gene mutations are frequent, alterations in network members like MDM2, MDM4 (mdmX), and miR-125b also disrupt its function.
• Understanding these complex interactions is crucial for cancer research and treatment.

Purpose of the Study:

• To review the fundamental features of wild-type and mutant TP53 proteins.
• To discuss animal models and clinical aspects, including patient care recommendations.
• To highlight the need for innovative strategies and standardized guidelines for TP53 variant reporting and annotation.

Main Methods:

• Review of existing literature on TP53 gene, proteins, and associated network members.
• Analysis of animal models relevant to TP53 research.
• Examination of clinical data and patient care guidelines related to TP53 alterations.
• Discussion of data standardization and annotation strategies for TP53 variants.

Main Results:

• The TP53 network is complex, with multiple mechanisms leading to pathway inactivation.
• Wild-type and mutant TP53 proteins exhibit diverse modifications and functions.
• Standardized reporting of TP53 variants is essential for data exchange and analysis across cancer databases.

Conclusions:

• The TP53 gene and its network are central to cancer development and progression.
• Innovative approaches and standardized data are necessary for accurate tumor profiling and improved patient care.
• This special issue provides a comprehensive overview to advance TP53 research in the post-genomic era.